ID   POMT2_HUMAN             Reviewed;         750 AA.
AC   Q9UKY4; Q9NSG6; Q9P1W0; Q9P1W2;
DT   20-JUN-2003, integrated into UniProtKB/Swiss-Prot.
DT   20-JUN-2003, sequence version 2.
DT   10-MAY-2017, entry version 154.
DE   RecName: Full=Protein O-mannosyl-transferase 2;
DE            EC=2.4.1.109;
DE   AltName: Full=Dolichyl-phosphate-mannose--protein mannosyltransferase 2;
GN   Name=POMT2;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ISOFORM 1), GLYCOSYLATION, AND
RP   SUBCELLULAR LOCATION.
RC   TISSUE=Cerebellum;
RX   PubMed=12460945; DOI=10.1093/glycob/cwf086;
RA   Willer T., Amselgruber W., Deutzmann R., Strahl S.;
RT   "Characterization of POMT2, a novel member of the PMT protein O-
RT   mannosyltransferase family specifically localized to the acrosome of
RT   mammalian spermatids.";
RL   Glycobiology 12:771-783(2002).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Neuroblastoma;
RA   Li W.B., Gruber C., Jessee J., Polayes D.;
RT   "Full-length cDNA libraries and normalization.";
RL   Submitted (FEB-2003) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=12508121; DOI=10.1038/nature01348;
RA   Heilig R., Eckenberg R., Petit J.-L., Fonknechten N., Da Silva C.,
RA   Cattolico L., Levy M., Barbe V., De Berardinis V., Ureta-Vidal A.,
RA   Pelletier E., Vico V., Anthouard V., Rowen L., Madan A., Qin S.,
RA   Sun H., Du H., Pepin K., Artiguenave F., Robert C., Cruaud C.,
RA   Bruels T., Jaillon O., Friedlander L., Samson G., Brottier P.,
RA   Cure S., Segurens B., Aniere F., Samain S., Crespeau H., Abbasi N.,
RA   Aiach N., Boscus D., Dickhoff R., Dors M., Dubois I., Friedman C.,
RA   Gouyvenoux M., James R., Madan A., Mairey-Estrada B., Mangenot S.,
RA   Martins N., Menard M., Oztas S., Ratcliffe A., Shaffer T., Trask B.,
RA   Vacherie B., Bellemere C., Belser C., Besnard-Gonnet M.,
RA   Bartol-Mavel D., Boutard M., Briez-Silla S., Combette S.,
RA   Dufosse-Laurent V., Ferron C., Lechaplais C., Louesse C., Muselet D.,
RA   Magdelenat G., Pateau E., Petit E., Sirvain-Trukniewicz P., Trybou A.,
RA   Vega-Czarny N., Bataille E., Bluet E., Bordelais I., Dubois M.,
RA   Dumont C., Guerin T., Haffray S., Hammadi R., Muanga J., Pellouin V.,
RA   Robert D., Wunderle E., Gauguet G., Roy A., Sainte-Marthe L.,
RA   Verdier J., Verdier-Discala C., Hillier L.W., Fulton L., McPherson J.,
RA   Matsuda F., Wilson R., Scarpelli C., Gyapay G., Wincker P., Saurin W.,
RA   Quetier F., Waterston R., Hood L., Weissenbach J.;
RT   "The DNA sequence and analysis of human chromosome 14.";
RL   Nature 421:601-607(2003).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 612-750.
RC   TISSUE=Testis;
RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;
RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H.,
RA   Heubner D., Hoerlein A., Michel G., Wedler H., Koehrer K.,
RA   Ottenwaelder B., Poustka A., Wiemann S., Schupp I.;
RT   "The full-ORF clone resource of the German cDNA consortium.";
RL   BMC Genomics 8:399-399(2007).
RN   [6]
RP   FUNCTION, CATALYTIC ACTIVITY, ENZYME REGULATION, AND SUBCELLULAR
RP   LOCATION.
RX   PubMed=14699049; DOI=10.1073/pnas.0307228101;
RA   Manya H., Chiba A., Yoshida A., Wang X., Chiba Y., Jigami Y.,
RA   Margolis R.U., Endo T.;
RT   "Demonstration of mammalian protein O-mannosyltransferase activity:
RT   coexpression of POMT1 and POMT2 required for enzymatic activity.";
RL   Proc. Natl. Acad. Sci. U.S.A. 101:500-505(2004).
RN   [7]
RP   INVOLVEMENT IN MDDGA2.
RX   PubMed=15894594; DOI=10.1136/jmg.2005.031963;
RA   van Reeuwijk J., Janssen M., van den Elzen C.,
RA   Beltran-Valero de Bernabe D., Sabatelli P., Merlini L., Boon M.,
RA   Scheffer H., Brockington M., Muntoni F., Huynen M.A., Verrips A.,
RA   Walsh C.A., Barth P.G., Brunner H.G., van Bokhoven H.;
RT   "POMT2 mutations cause alpha-dystroglycan hypoglycosylation and
RT   Walker-Warburg syndrome.";
RL   J. Med. Genet. 42:907-912(2005).
RN   [8]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-41, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [9]
RP   VARIANTS MDDGA2 SER-353 AND GLU-726.
RX   PubMed=16701995; DOI=10.1016/j.nmd.2006.03.016;
RA   Mercuri E., D'Amico A., Tessa A., Berardinelli A., Pane M.,
RA   Messina S., van Reeuwijk J., Bertini E., Muntoni F., Santorelli F.M.;
RT   "POMT2 mutation in a patient with 'MEB-like' phenotype.";
RL   Neuromuscul. Disord. 16:446-448(2006).
RN   [10]
RP   VARIANT MDDGC2 MET-184.
RX   PubMed=17923109; DOI=10.1016/j.bbrc.2007.09.066;
RA   Biancheri R., Falace A., Tessa A., Pedemonte M., Scapolan S.,
RA   Cassandrini D., Aiello C., Rossi A., Broda P., Zara F.,
RA   Santorelli F.M., Minetti C., Bruno C.;
RT   "POMT2 gene mutation in limb-girdle muscular dystrophy with
RT   inflammatory changes.";
RL   Biochem. Biophys. Res. Commun. 363:1033-1037(2007).
RN   [11]
RP   VARIANTS MDDGA2 ASN-198; PHE-373; PRO-413 AND CYS-666, AND VARIANTS
RP   MDDGC2 MET-184 AND SER-748.
RX   PubMed=17878207; DOI=10.1093/brain/awm212;
RA   Godfrey C., Clement E., Mein R., Brockington M., Smith J., Talim B.,
RA   Straub V., Robb S., Quinlivan R., Feng L., Jimenez-Mallebrera C.,
RA   Mercuri E., Manzur A.Y., Kinali M., Torelli S., Brown S.C.,
RA   Sewry C.A., Bushby K., Topaloglu H., North K., Abbs S., Muntoni F.;
RT   "Refining genotype phenotype correlations in muscular dystrophies with
RT   defective glycosylation of dystroglycan.";
RL   Brain 130:2725-2735(2007).
RN   [12]
RP   VARIANTS MDDGB2 CYS-666 AND ARG-748.
RX   PubMed=17634419; DOI=10.1212/01.wnl.0000268489.60809.c4;
RA   Yanagisawa A., Bouchet C., Van den Bergh P.Y., Cuisset J.M.,
RA   Viollet L., Leturcq F., Romero N.B., Quijano-Roy S., Fardeau M.,
RA   Seta N., Guicheney P.;
RT   "New POMT2 mutations causing congenital muscular dystrophy:
RT   identification of a founder mutation.";
RL   Neurology 69:1254-1260(2007).
RN   [13]
RP   VARIANTS MDDGA2 VAL-482; 444-ILE-ASN-445 DELINS LEU-LEU-TRP-GLN AND
RP   CYS-666.
RX   PubMed=19138766; DOI=10.1016/j.ejmg.2008.12.004;
RA   Yanagisawa A., Bouchet C., Quijano-Roy S., Vuillaumier-Barrot S.,
RA   Clarke N., Odent S., Rodriguez D., Romero N.B., Osawa M., Endo T.,
RA   Taratuto A.L., Seta N., Guicheney P.;
RT   "POMT2 intragenic deletions and splicing abnormalities causing
RT   congenital muscular dystrophy with mental retardation.";
RL   Eur. J. Med. Genet. 52:201-206(2009).
RN   [14]
RP   VARIANTS MDDGB2 ASP-246; SER-353; CYS-666 AND GLU-726.
RX   PubMed=19299310; DOI=10.1212/01.wnl.0000346518.68110.60;
RA   Mercuri E., Messina S., Bruno C., Mora M., Pegoraro E., Comi G.P.,
RA   D'Amico A., Aiello C., Biancheri R., Berardinelli A., Boffi P.,
RA   Cassandrini D., Laverda A., Moggio M., Morandi L., Moroni I., Pane M.,
RA   Pezzani R., Pichiecchio A., Pini A., Minetti C., Mongini T.,
RA   Mottarelli E., Ricci E., Ruggieri A., Saredi S., Scuderi C., Tessa A.,
RA   Toscano A., Tortorella G., Trevisan C.P., Uggetti C., Vasco G.,
RA   Santorelli F.M., Bertini E.;
RT   "Congenital muscular dystrophies with defective glycosylation of
RT   dystroglycan: a population study.";
RL   Neurology 72:1802-1809(2009).
RN   [15]
RP   VARIANT MDDGA2 ARG-478.
RX   PubMed=22958903; DOI=10.1016/j.ajhg.2012.07.009;
RA   Manzini M.C., Tambunan D.E., Hill R.S., Yu T.W., Maynard T.M.,
RA   Heinzen E.L., Shianna K.V., Stevens C.R., Partlow J.N., Barry B.J.,
RA   Rodriguez J., Gupta V.A., Al-Qudah A.K., Eyaid W.M., Friedman J.M.,
RA   Salih M.A., Clark R., Moroni I., Mora M., Beggs A.H., Gabriel S.B.,
RA   Walsh C.A.;
RT   "Exome sequencing and functional validation in zebrafish identify
RT   GTDC2 mutations as a cause of Walker-Warburg syndrome.";
RL   Am. J. Hum. Genet. 91:541-547(2012).
CC   -!- FUNCTION: Transfers mannosyl residues to the hydroxyl group of
CC       serine or threonine residues. Coexpression of both POMT1 and POMT2
CC       is necessary for enzyme activity, expression of either POMT1 or
CC       POMT2 alone is insufficient. {ECO:0000269|PubMed:14699049}.
CC   -!- CATALYTIC ACTIVITY: Dolichyl D-mannosyl phosphate + protein =
CC       dolichyl phosphate + O-D-mannosylprotein.
CC       {ECO:0000269|PubMed:14699049}.
CC   -!- ENZYME REGULATION: Slightly activated by Mg(2+) and inhibited by
CC       both Ca(+) and Mn(2+). EDTA ha no effect on activity in vitro.
CC       {ECO:0000269|PubMed:14699049}.
CC   -!- PATHWAY: Protein modification; protein glycosylation.
CC   -!- SUBUNIT: Interacts with POMT1. {ECO:0000305}.
CC   -!- SUBCELLULAR LOCATION: Endoplasmic reticulum membrane
CC       {ECO:0000269|PubMed:12460945, ECO:0000269|PubMed:14699049}; Multi-
CC       pass membrane protein {ECO:0000269|PubMed:12460945,
CC       ECO:0000269|PubMed:14699049}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q9UKY4-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q9UKY4-2; Sequence=VSP_041457;
CC         Note=May be produced at very low levels due to a premature stop
CC         codon in the mRNA, leading to nonsense-mediated mRNA decay. No
CC         experimental confirmation available.;
CC   -!- TISSUE SPECIFICITY: Highly expressed in testis; detected at low
CC       levels in most tissues.
CC   -!- PTM: N-glycosylated. {ECO:0000269|PubMed:12460945}.
CC   -!- DISEASE: Muscular dystrophy-dystroglycanopathy congenital with
CC       brain and eye anomalies A2 (MDDGA2) [MIM:613150]: An autosomal
CC       recessive disorder characterized by congenital muscular dystrophy
CC       associated with cobblestone lissencephaly and other brain
CC       anomalies, eye malformations, profound mental retardation, and
CC       death usually in the first years of life. Included diseases are
CC       the more severe Walker-Warburg syndrome and the slightly less
CC       severe muscle-eye-brain disease. {ECO:0000269|PubMed:15894594,
CC       ECO:0000269|PubMed:16701995, ECO:0000269|PubMed:17878207,
CC       ECO:0000269|PubMed:19138766, ECO:0000269|PubMed:22958903}.
CC       Note=The disease is caused by mutations affecting the gene
CC       represented in this entry.
CC   -!- DISEASE: Muscular dystrophy-dystroglycanopathy congenital with
CC       mental retardation B2 (MDDGB2) [MIM:613156]: An autosomal
CC       recessive disorder characterized by congenital muscular dystrophy
CC       associated with mental retardation and mild structural brain
CC       abnormalities. {ECO:0000269|PubMed:17634419,
CC       ECO:0000269|PubMed:19299310}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- DISEASE: Muscular dystrophy-dystroglycanopathy limb-girdle C2
CC       (MDDGC2) [MIM:613158]: An autosomal recessive muscular dystrophy
CC       with onset after ambulation is achieved. MDDGC2 is characterized
CC       by increased serum creatine kinase and mild muscle weakness.
CC       Muscle biopsy shows dystrophic changes, inflammatory changes, and
CC       severely decreased alpha-dystroglycan. Cognition is normal.
CC       {ECO:0000269|PubMed:17878207, ECO:0000269|PubMed:17923109}.
CC       Note=The disease is caused by mutations affecting the gene
CC       represented in this entry.
CC   -!- SIMILARITY: Belongs to the glycosyltransferase 39 family.
CC       {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=CAD62348.1; Type=Erroneous translation; Note=Wrong choice of frame.; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF105020; AAF14118.1; -; mRNA.
DR   EMBL; AY090480; AAM12046.1; -; mRNA.
DR   EMBL; BX248027; CAD62348.1; ALT_SEQ; mRNA.
DR   EMBL; AC007954; AAF62558.1; -; Genomic_DNA.
DR   EMBL; AC007375; AAF63184.1; -; Genomic_DNA.
DR   EMBL; BC031651; AAH31651.1; -; mRNA.
DR   EMBL; AL353956; CAB89256.1; -; mRNA.
DR   CCDS; CCDS9857.1; -. [Q9UKY4-1]
DR   PIR; T48691; T48691.
DR   RefSeq; NP_037514.2; NM_013382.5. [Q9UKY4-1]
DR   UniGene; Hs.132989; -.
DR   ProteinModelPortal; Q9UKY4; -.
DR   SMR; Q9UKY4; -.
DR   BioGrid; 118991; 21.
DR   STRING; 9606.ENSP00000261534; -.
DR   CAZy; GT39; Glycosyltransferase Family 39.
DR   iPTMnet; Q9UKY4; -.
DR   PhosphoSitePlus; Q9UKY4; -.
DR   BioMuta; POMT2; -.
DR   DMDM; 32171723; -.
DR   EPD; Q9UKY4; -.
DR   PaxDb; Q9UKY4; -.
DR   PeptideAtlas; Q9UKY4; -.
DR   PRIDE; Q9UKY4; -.
DR   DNASU; 29954; -.
DR   Ensembl; ENST00000261534; ENSP00000261534; ENSG00000009830. [Q9UKY4-1]
DR   Ensembl; ENST00000556326; ENSP00000450630; ENSG00000009830. [Q9UKY4-2]
DR   GeneID; 29954; -.
DR   KEGG; hsa:29954; -.
DR   UCSC; uc001xti.3; human. [Q9UKY4-1]
DR   CTD; 29954; -.
DR   DisGeNET; 29954; -.
DR   GeneCards; POMT2; -.
DR   GeneReviews; POMT2; -.
DR   H-InvDB; HIX0011845; -.
DR   HGNC; HGNC:19743; POMT2.
DR   HPA; HPA003663; -.
DR   MalaCards; POMT2; -.
DR   MIM; 607439; gene.
DR   MIM; 613150; phenotype.
DR   MIM; 613156; phenotype.
DR   MIM; 613158; phenotype.
DR   neXtProt; NX_Q9UKY4; -.
DR   OpenTargets; ENSG00000009830; -.
DR   Orphanet; 206559; Autosomal recessive limb-girdle muscular dystrophy type 2N.
DR   Orphanet; 370959; Congenital muscular dystrophy with cerebellar involvement.
DR   Orphanet; 370968; Congenital muscular dystrophy with intellectual disability.
DR   Orphanet; 588; Muscle-eye-brain disease.
DR   Orphanet; 899; Walker-Warburg syndrome.
DR   PharmGKB; PA134980627; -.
DR   eggNOG; KOG3359; Eukaryota.
DR   eggNOG; COG1928; LUCA.
DR   GeneTree; ENSGT00870000136482; -.
DR   HOGENOM; HOG000157526; -.
DR   HOVERGEN; HBG096391; -.
DR   InParanoid; Q9UKY4; -.
DR   KO; K00728; -.
DR   OMA; TIEDLWE; -.
DR   OrthoDB; EOG091G02QX; -.
DR   PhylomeDB; Q9UKY4; -.
DR   TreeFam; TF300552; -.
DR   BRENDA; 2.4.1.109; 2681.
DR   Reactome; R-HSA-5173105; O-linked glycosylation.
DR   UniPathway; UPA00378; -.
DR   ChiTaRS; POMT2; human.
DR   GeneWiki; POMT2; -.
DR   GenomeRNAi; 29954; -.
DR   PRO; PR:Q9UKY4; -.
DR   Proteomes; UP000005640; Chromosome 14.
DR   Bgee; ENSG00000009830; -.
DR   CleanEx; HS_POMT2; -.
DR   ExpressionAtlas; Q9UKY4; baseline and differential.
DR   Genevisible; Q9UKY4; HS.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; IBA:GO_Central.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0004169; F:dolichyl-phosphate-mannose-protein mannosyltransferase activity; IBA:GO_Central.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0071712; P:ER-associated misfolded protein catabolic process; IBA:GO_Central.
DR   GO; GO:1904100; P:positive regulation of protein O-linked glycosylation; IEA:Ensembl.
DR   GO; GO:0006493; P:protein O-linked glycosylation; TAS:Reactome.
DR   InterPro; IPR027005; GlyclTrfase_39-like.
DR   InterPro; IPR003342; Glyco_trans_39/83.
DR   InterPro; IPR016093; MIR_motif.
DR   InterPro; IPR032421; PMT_4TMC.
DR   PANTHER; PTHR10050; PTHR10050; 1.
DR   Pfam; PF02815; MIR; 1.
DR   Pfam; PF02366; PMT; 1.
DR   Pfam; PF16192; PMT_4TMC; 1.
DR   SMART; SM00472; MIR; 3.
DR   SUPFAM; SSF82109; SSF82109; 1.
DR   PROSITE; PS50919; MIR; 3.
PE   1: Evidence at protein level;
KW   Alternative splicing; Complete proteome;
KW   Congenital muscular dystrophy; Dystroglycanopathy;
KW   Endoplasmic reticulum; Glycoprotein; Glycosyltransferase;
KW   Limb-girdle muscular dystrophy; Lissencephaly; Membrane;
KW   Metal-binding; Phosphoprotein; Polymorphism; Reference proteome;
KW   Repeat; Transferase; Transmembrane; Transmembrane helix.
FT   CHAIN         1    750       Protein O-mannosyl-transferase 2.
FT                                /FTId=PRO_0000121488.
FT   TRANSMEM     54     74       Helical. {ECO:0000255}.
FT   TRANSMEM    100    120       Helical. {ECO:0000255}.
FT   TRANSMEM    146    166       Helical. {ECO:0000255}.
FT   TRANSMEM    191    211       Helical. {ECO:0000255}.
FT   TRANSMEM    231    251       Helical. {ECO:0000255}.
FT   TRANSMEM    283    303       Helical. {ECO:0000255}.
FT   TRANSMEM    596    616       Helical. {ECO:0000255}.
FT   TRANSMEM    643    663       Helical. {ECO:0000255}.
FT   TRANSMEM    665    685       Helical. {ECO:0000255}.
FT   TRANSMEM    700    720       Helical. {ECO:0000255}.
FT   DOMAIN      334    390       MIR 1. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00131}.
FT   DOMAIN      403    459       MIR 2. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00131}.
FT   DOMAIN      464    521       MIR 3. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00131}.
FT   MOD_RES      41     41       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   CARBOHYD     98     98       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    330    330       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    445    445       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    528    528       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    583    583       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   VAR_SEQ      83    750       Missing (in isoform 2).
FT                                {ECO:0000303|Ref.2}.
FT                                /FTId=VSP_041457.
FT   VARIANT      54     54       A -> E (in dbSNP:rs8177536).
FT                                /FTId=VAR_022083.
FT   VARIANT     184    184       T -> M (in MDDGC2; dbSNP:rs267606971).
FT                                {ECO:0000269|PubMed:17878207,
FT                                ECO:0000269|PubMed:17923109}.
FT                                /FTId=VAR_065037.
FT   VARIANT     198    198       I -> N (in MDDGA2; dbSNP:rs267606972).
FT                                {ECO:0000269|PubMed:17878207}.
FT                                /FTId=VAR_065038.
FT   VARIANT     246    246       G -> D (in MDDGB2; dbSNP:rs267606966).
FT                                {ECO:0000269|PubMed:19299310}.
FT                                /FTId=VAR_065039.
FT   VARIANT     353    353       G -> S (in MDDGA2; dbSNP:rs267606970).
FT                                {ECO:0000269|PubMed:16701995,
FT                                ECO:0000269|PubMed:19299310}.
FT                                /FTId=VAR_065040.
FT   VARIANT     373    373       V -> F (in MDDGA2; dbSNP:rs267606965).
FT                                {ECO:0000269|PubMed:17878207}.
FT                                /FTId=VAR_065041.
FT   VARIANT     413    413       R -> P (in MDDGA2; dbSNP:rs190285831).
FT                                {ECO:0000269|PubMed:17878207}.
FT                                /FTId=VAR_065042.
FT   VARIANT     444    445       IN -> LLWQ (in MDDGA2).
FT                                {ECO:0000269|PubMed:19138766}.
FT                                /FTId=VAR_065043.
FT   VARIANT     478    478       H -> R (in MDDGA2; dbSNP:rs765346043).
FT                                {ECO:0000269|PubMed:22958903}.
FT                                /FTId=VAR_068968.
FT   VARIANT     482    482       G -> V (in MDDGA2; dbSNP:rs267606968).
FT                                {ECO:0000269|PubMed:19138766}.
FT                                /FTId=VAR_065044.
FT   VARIANT     666    666       Y -> C (in MDDGB2 and MDDGA2;
FT                                dbSNP:rs200198778).
FT                                {ECO:0000269|PubMed:17634419,
FT                                ECO:0000269|PubMed:17878207,
FT                                ECO:0000269|PubMed:19138766,
FT                                ECO:0000269|PubMed:19299310}.
FT                                /FTId=VAR_065045.
FT   VARIANT     717    717       F -> S (in MDDGB2).
FT                                /FTId=VAR_065046.
FT   VARIANT     726    726       G -> E (in MDDGA2 and MDDGB2;
FT                                dbSNP:rs267606969).
FT                                {ECO:0000269|PubMed:16701995,
FT                                ECO:0000269|PubMed:19299310}.
FT                                /FTId=VAR_065047.
FT   VARIANT     748    748       W -> R (in MDDGB2; dbSNP:rs267606964).
FT                                {ECO:0000269|PubMed:17634419}.
FT                                /FTId=VAR_065048.
FT   VARIANT     748    748       W -> S (in MDDGC2; dbSNP:rs267606967).
FT                                {ECO:0000269|PubMed:17878207}.
FT                                /FTId=VAR_065049.
FT   CONFLICT     53     53       E -> Q (in Ref. 1; AAF14118/AAM12046).
FT                                {ECO:0000305}.
SQ   SEQUENCE   750 AA;  84214 MW;  79732D6C4978CFB9 CRC64;
     MPPATGGGLA ESELRPRRGR CGPQAARAAG RDVAAEAVAR SPKRPAWGSR RFEAVGWWAL
     LALVTLLSFA TRFHRLDEPP HICWDETHFG KMGSYYINRT FFFDVHPPLG KMLIGLAGYL
     SGYDGTFLFQ KPGDKYEHHS YMGMRGFCAF LGSWLVPFAY LTVLDLSKSL SAALLTAALL
     TFDTGCLTLS QYILLDPILM FFIMAAMLSM VKYNSCADRP FSAPWWFWLS LTGVSLAGAL
     GVKFVGLFII LQVGLNTIAD LWYLFGDLSL SLVTVGKHLT ARVLCLIVLP LALYTATFAV
     HFMVLSKSGP GDGFFSSAFQ ARLSGNNLHN ASIPEHLAYG SVITVKNLRM AIGYLHSHRH
     LYPEGIGARQ QQVTTYLHKD YNNLWIIKKH NTNSDPLDPS FPVEFVRHGD IIRLEHKETS
     RNLHSHYHEA PMTRKHYQVT GYGINGTGDS NDFWRIEVVN RKFGNRIKVL RSRIRFIHLV
     TGCVLGSSGK VLPKWGWEQL EVTCTPYLKE TLNSIWNVED HINPKLPNIS LDVLQPSFPE
     ILLESHMVMI RGNSGLKPKD NEFTSKPWHW PINYQGLRFS GVNDTDFRVY LLGNPVVWWL
     NLLSIALYLL SGSIIAVAMQ RGARLPAEVA GLSQVLLRGG GQVLLGWTLH YFPFFLMGRV
     LYFHHYFPAM LFSSMLTGIL WDTLLRLCAW GLASWPLARG IHVAGILSLL LGTAYSFYLF
     HPLAYGMVGP LAQDPQSPMA GLRWLDSWDF
//
